0001380106false00013801062023-07-142023-07-14

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): September 26, 2023
RAPID MICRO BIOSYSTEMS, INC.
(Exact name of registrant as specified in its charter)
Delaware001-4059220-8121647
(State or other jurisdiction
of incorporation or organization)		(Commission
File Number)		(I.R.S. Employer
Identification No.)
 1001 Pawtucket Boulevard West, Suite 280, Lowell, MA
01854
(Address of principal executive offices)
(Zip Code)
978-349-3200
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbols		Name of each exchange on which
registered
Class A Common Stock, $0.01 par value per shareRPIDThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company þ
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



Item 8.01
Other Events.
As previously reported, on September 13, 2023, Rapid Micro Biosystems, Inc. (the “Company”) received a notification letter from the Nasdaq Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC notifying the Company that the bid price for the Company’s Class A common stock, par value $0.01 (the “common stock”) had closed below $1.00 per share for thirty (30) consecutive business days (July 31, 2023 through September 11, 2023) and that, as a result, the Company was not in compliance with the minimum bid price requirement for continued inclusion on the Nasdaq Global Select Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The Company was provided a period of 180 calendar days, until March 11, 2024, to regain compliance with the Bid Price Requirement.

On September 26, 2023, the Company was informed by the Staff that it had regained compliance with the Bid Price Requirement following ten (10) consecutive business days (September 12, 2023 through September 25, 2023) during which the closing bid price of Company’s common stock was equal to or greater than $1.00 per share, and that this matter was closed.




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
RAPID MICRO BIOSYSTEMS, INC.
Date: September 26, 2023By:/s/ Sean Wirtjes
Sean Wirtjes
Chief Financial Officer

v3.23.3
Cover Page
Jul. 14, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Sep. 26, 2023
Entity Registrant Name RAPID MICRO BIOSYSTEMS, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-40592
Entity Tax Identification Number 20-8121647
Entity Address, Address Line One 1001 Pawtucket Boulevard West
Entity Address, Address Line Two Suite 280
Entity Address, City or Town Lowell,
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01854
City Area Code 978
Local Phone Number 349-3200
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A Common Stock, $0.01 par value per share
Trading Symbol RPID
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001380106
Amendment Flag false
Rapid Micro Biosystems (NASDAQ:RPID)
Historical Stock Chart
Von Apr 2024 bis Mai 2024 Click Here for more Rapid Micro Biosystems Charts.
Rapid Micro Biosystems (NASDAQ:RPID)
Historical Stock Chart
Von Mai 2023 bis Mai 2024 Click Here for more Rapid Micro Biosystems Charts.